Wells Fargo
PYXS icon

Wells Fargo’s Pyxis Oncology PYXS Stock Holding History

Wells Fargo’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$416 Sell
285
-2,000
-88% -$3.01K ﹤0.01% 6413
2025
Q4 		$2.63K Buy
2,285
+2,000
+702% +$7.05K ﹤0.01% 6193
2025
Q3 		$633 Sell
285
-414
-59% -$596 ﹤0.01% 6285
2025
Q2 		$769 Sell
699
-29,191
-98% -$32.9K ﹤0.01% 6336
2025
Q1 		$29.3K Buy
29,890
+941
+3% +$1.25K ﹤0.01% 5579
2024
Q4 		$45.2K Buy
28,949
+4,724
+20% +$13.6K ﹤0.01% 5518
2024
Q3 		$88.9K Buy
24,225
+2,183
+10% +$7.64K ﹤0.01% 5085
2024
Q2 		$73K Buy
22,042
+21,208
+2,543% +$89.2K ﹤0.01% 5121
2024
Q1 		$3.55K Sell
834
-1,697
-67% -$7.14K ﹤0.01% 5946
2023
Q4 		$4.56K Buy
2,531
+23
+0.9% +$39 ﹤0.01% 5972
2023
Q3 		$4.99K Buy
2,508
+38
+2% +$88 ﹤0.01% 5956
2023
Q2 		$6.32K Buy
2,470
+307
+14% +$974 ﹤0.01% 6035
2023
Q1 		$8.67K Buy
2,163
+2,003
+1,252% +$4K ﹤0.01% 5906
2022
Q4 		$214 Buy
160
+14
+10% +$21 ﹤0.01% 6601
2022
Q3 		$0 Buy
146
+76
+109% +$199 ﹤0.01% 7212
2022
Q2 		$0 Sell
70
-5,245
-99% -$14K ﹤0.01% 7334
2022
Q1 		$21K Sell
5,315
-6,099
-53% -$44.6K ﹤0.01% 5993
2021
Q4 		$125K Buy
+11,414
New +$131K ﹤0.01% 5517

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo's PYXS Position: Q1 2026 in Review

Wells Fargo reduced its Pyxis Oncology (PYXS) stake by 88% in Q1 2026, selling an estimated $3.01K and leaving 285 shares worth $416. The position accounts for ﹤0.01% of the portfolio, ranked #6413.

Wells Fargo first reported a position in PYXS in Q4 2021 and has held it in 18 quarters since. The position peaked at $125K in Q4 2021. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Wells Fargo held 285 shares of Pyxis Oncology worth $416 as of Q1 2026.
  • Wells Fargo sold 2,000 Pyxis Oncology shares in Q1 2026, an estimated $3.01K.
  • Pyxis Oncology made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6413 holding.
  • Wells Fargo first reported a position in Pyxis Oncology in Q4 2021 and has held it in 18 quarters since.
  • Wells Fargo's Pyxis Oncology position peaked at $125K in Q4 2021.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.